Avalon Leads $18M in Early Funding for Cancer Immunotherapy Startup
Xconomy
SEPTEMBER 27, 2016
[ Note: The headline has been corrected to better describe the company’s type of funding. Fortis Therapeutics, a new San Diego biotech, has raised $18 million in initial funding to develop drugs for hard-to-treat prostate and bone marrow cancers. 9/27/16, 2:09 p.m. Bregua Corp., We’re not inventing anything on the ADC,” he said.
Let's personalize your content